Skip to main content
SpringerLink
Log in

Traditional and emerging therapies are useful in the treatment of short bowel syndrome in children

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table 1
Table 2
Table 3

References

  1. Vanderhoof JA. Short bowel syndrome and intestinal adaptation. In: Walker WA, Durie PR, Hamilton JR, et al., editors. Pediatric gastrointestinal disease. 3rd ed. Hamilton: BC Decker, 2000: 583–602.

    Google Scholar 

  2. Vanderhoof JA, Young RJ, Thompson JS. New and emerging therapies for short bowel syndrome in children. Pediatr Drugs 2003; 5 (8): 525–31.

    Article  Google Scholar 

  3. Vanderhoof JA, Langnas AN. Short bowel syndrome in children and adults. Gastroenterology 1997; 113: 1767–78.

    Article  PubMed  CAS  Google Scholar 

  4. Vanderhoof JA. Short bowel syndrome: parenteral nutrition versus intestinal transplantation. Ped Nutr ISPEN 1999; 1 (1): 8–15.

    Google Scholar 

  5. Kelly DA. Liver complications of pediatric parenteral nutrition: epidemiology. Nutrition 1998; 14 (1): 153–7.

    Article  PubMed  CAS  Google Scholar 

  6. Vanderhoof JA. Short bowel syndrome. In: Walker WA, Watkins JB, editors. Nutrition in pediatrics. 2nd ed. Hamilton: BC Decker, 1996: 609–18.

    Google Scholar 

  7. Byrne TA, Persinger RL, Young LS, et al. A new treatment for patients with short bowel syndrome: growth hormone, glutamine, and a modified diet. Ann Surg 1995; 222 (3): 243–54.

    Article  PubMed  CAS  Google Scholar 

  8. Scolapio JS, Camilleri M, Fleming CR, et al. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology 1997; 113 (4): 1402–5.

    Article  Google Scholar 

  9. Szkudlarek J, Jeppesen PB, Mortensen PB. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomized, double-blind, placebo controlled study. Gut 2000; 47 (2): 199–205.

    Article  PubMed  CAS  Google Scholar 

  10. Jeppesen PB, Szkudlarek J, Hoy CE, et al. Effect of high-dose growth hormone and glutamine on body composition, urine creatinine excretion, fatty acid absorption and essential fatty acids status in short bowel patients: a randomized, double-blind, placebo-controlled study. Scand J Gastroenterol 2001; 36 (1): 48–54.

    Article  PubMed  CAS  Google Scholar 

  11. Jeppesen PB, Harmann B, Thulesen J, et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short bowel patients with no colon. Gastroenterology 2001; 120: 806–15.

    Article  PubMed  CAS  Google Scholar 

  12. Nehra V, Camilleri M, Burton D, et al. An open trial of octreotide long-acting release in the management of short bowel syndrome. Am J Gastroenterol 2001; 96: 1494–8.

    Article  PubMed  CAS  Google Scholar 

  13. Warner BW, Ziegler MM. Management of the short bowel syndrome in the pediatric population. Pediatr Clin North Am 1993; 40 (6): 1335–50.

    PubMed  CAS  Google Scholar 

  14. Bianchi A. Intestinal lengthening: an experimental and clinical review. J R Soc Med 1984; 77: 35–41.

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Traditional and emerging therapies are useful in the treatment of short bowel syndrome in children. Drugs Ther. Perspect 20, 14–17 (2004). https://doi.org/10.2165/00042310-200420030-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200420030-00005

Keywords

Search

Navigation